French Registry of CMR Late Gadolinium Enhancement in Myocarditis
ConditionMyocarditis Acute
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
Acute myocarditis is a major cause of death in young adults and carries substantial morbidity, including a significant risk of progression to dilated cardiomyopathy. Current diagnostic and therapeutic strategies remain poorly defined, making risk stratification crucial to enable personalized treatments and reduce mortality and major cardiovascular events.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
Ability to provide informed non-opposition
AM diagnosis confirmed using CMR, fulfilling the modified Lake Louise diagnostic criteria
Disqualifiers
None
Trial population
The study will include all consecutive patients with AM referred for CMR assessment.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
All-cause mortality
All-cause mortality defined using the French national registry of death (INSEE).
Time frame
From enrollment to the end of follow up at 10 yearsSecondary outcomes
1
All-cause death
Time frame
From enrollment to the end of follow up at 10 years2
Heart transplantation
Time frame
From enrollment to the end of follow up at 10 years3
Ventricular arrhythmia
Time frame
From enrollment to the end of follow up at 10 years4
Hospitalisation for acute heart failure
Time frame
From enrollment to the end of follow up at 10 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: